Cargando…

Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses

Although Plasmodium vivax relapses are classically associated with hypnozoite activation, it has been proposed that a proportion of these cases are due to primaquine (PQ) treatment failure caused by polymorphisms in cytochrome P-450 2D6 (CYP2D6). Here, we present evidence that CYP2D6 polymorphisms a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silvino, Ana Carolina Rios, Costa, Gabriel Luiz, de Araújo, Flávia Carolina Faustino, Ascher, David Benjamin, Pires, Douglas Eduardo Valente, Fontes, Cor Jesus Fernandes, Carvalho, Luzia Helena, de Brito, Cristiana Ferreira Alves, Sousa, Tais Nobrega
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965052/ https://www.ncbi.nlm.nih.gov/pubmed/27467145 http://dx.doi.org/10.1371/journal.pone.0160172

Ejemplares similares

Correction: Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses
por: Silvino, Ana Carolina Rios, et al.
Publicado: (2018)

Assessment of copy number variation in genes related to drug resistance in Plasmodium vivax and Plasmodium falciparum isolates from the Brazilian Amazon and a systematic review of the literature
por: Costa, Gabriel Luíz, et al.
Publicado: (2017)

Worldwide Genetic Variability of the Duffy Binding Protein: Insights into Plasmodium vivax Vaccine Development
por: Nóbrega de Sousa, Taís, et al.
Publicado: (2011)

Multiple-Clone Activation of Hypnozoites Is the Leading Cause of Relapse in Plasmodium vivax Infection
por: de Araujo, Flávia Carolina F., et al.
Publicado: (2012)

Multiple-clone infections of Plasmodium vivax: definition of a panel of markers for molecular epidemiology
por: de Souza, Aracele M., et al.
Publicado: (2015)

The Duffy binding protein as a key target for a Plasmodium vivax vaccine: lessons from the Brazilian Amazon
por: de Sousa, Taís Nóbrega, et al.
Publicado: (2014)

Genetic variability of Plasmodium vivax from primary–relapses paired samples
por: Araujo, Flávia C, et al.
Publicado: (2012)

Augmented plasma microparticles during acute Plasmodium vivax infection
por: Campos, Fernanda MF, et al.
Publicado: (2010)

Susceptibility to Plasmodium vivax malaria associated with DARC (Duffy antigen) polymorphisms is influenced by the time of exposure to malaria
por: Kano, Flora Satiko, et al.
Publicado: (2018)

Genetic variability and natural selection at the ligand domain of the Duffy binding protein in brazilian Plasmodium vivax populations
por: Sousa, Taís N, et al.
Publicado: (2010)

The Presence, Persistence and Functional Properties of Plasmodium vivax Duffy Binding Protein II Antibodies Are Influenced by HLA Class II Allelic Variants
por: Kano, Flora S., et al.
Publicado: (2016)

Plasmodium simium, a Plasmodium vivax-Related Malaria Parasite: Genetic Variability of Duffy Binding Protein II and the Duffy Antigen/Receptor for Chemokines
por: Camargos Costa, Daniela, et al.
Publicado: (2015)

Plasma Circulating Nucleic Acids Levels Increase According to the Morbidity of Plasmodium vivax Malaria
por: Franklin, Bernardo S., et al.
Publicado: (2011)

The Interface Between Inflammatory Mediators and MicroRNAs in Plasmodium vivax Severe Thrombocytopenia
por: Santos, Marina L. S., et al.
Publicado: (2021)

Plasmodium vivax infection: atypical memory B cells are expanded and associated with the persistence of Duffy binding protein II (DBPII) antibody response
por: Kano, Flora S, et al.
Publicado: (2014)

Adherence to Plasmodium vivax malaria treatment in the Brazilian Amazon Region
por: Pereira, Elza A, et al.
Publicado: (2011)

Plasmodium vivax Landscape in Brazil: Scenario and Challenges
por: Siqueira, Andre M., et al.
Publicado: (2016)

Impact of Epstein-Barr virus co-infection on natural acquired Plasmodium vivax antibody response
por: Dias, Michelle H. F., et al.
Publicado: (2022)

Distinct HLA class II alleles influence antibody response to the Plasmodium vivax Duffy binding protein
por: Kano, Flora S, et al.
Publicado: (2014)

Plasmodium simium/Plasmodium vivax infections in southern brown howler monkeys from the Atlantic Forest
por: Costa, Daniela Camargos, et al.
Publicado: (2014)

Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases
por: de Pina-Costa, Anielle, et al.
Publicado: (2021)

A Comprehensive Analysis of the Genetic Diversity of Plasmodium falciparum Histidine-Rich Protein 2 (PfHRP2) in the Brazilian Amazon
por: Costa, Gabriel Luíz, et al.
Publicado: (2021)

Blood-stage Plasmodium vivax antibody dynamics in a low transmission setting: A nine year follow-up study in the Amazon region
por: Pires, Camilla V., et al.
Publicado: (2018)

Analysis of lymphocytes in patients with Plasmodium vivax malaria and its relation to the annexin-A1 and IL-10
por: Borges, Quessi I, et al.
Publicado: (2013)

Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions
por: Ferreira, Marcelo U., et al.
Publicado: (2020)

Polymorphism at the apical membrane antigen 1 locus reflects the world population history of Plasmodium vivax
por: Grynberg, Priscila, et al.
Publicado: (2008)

Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function
por: Martin Ramírez, Alexandra, et al.
Publicado: (2020)

Probing the Role of the Hinge Segment of Cytochrome P450 Oxidoreductase in the Interaction with Cytochrome P450
por: Campelo, Diana, et al.
Publicado: (2018)

The effect of SNPs in CYP450 in chloroquine/primaquine Plasmodium vivax malaria treatment
por: Sortica, Vinicius A, et al.
Publicado: (2016)

Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria
por: Baird, J. Kevin, et al.
Publicado: (2018)

Four Times of Relapse of Plasmodium vivax Malaria Despite Primaquine Treatment in a Patient with Impaired Cytochrome P450 2D6 Function
por: Choi, Sungim, et al.
Publicado: (2022)

Improving N-terminal protein annotation of Plasmodium species based on signal peptide prediction of orthologous proteins
por: Neto, Armando de Menezes, et al.
Publicado: (2012)

Preliminary assessment of anti-α-Gal IgG and IgM levels in patients with patent Plasmodium vivax infection
por: Coelho, Zélia Barbosa de Almeida, et al.
Publicado: (2019)

Is zoonotic Plasmodium vivax malaria an obstacle for disease elimination?
por: Chaves, Bárbara Aparecida, et al.
Publicado: (2022)

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms
por: Baird, J. Kevin, et al.
Publicado: (2018)

1-Aminobenzotriazole: A Mechanism-Based Cytochrome P450 Inhibitor and Probe of Cytochrome P450 Biology
por: de Montellano, Paul R Ortiz
Publicado: (2018)

Ribosomal and non-ribosomal PCR targets for the detection of low-density and mixed malaria infections
por: Amaral, Lara Cotta, et al.
Publicado: (2019)

Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax
por: Guedes, Karla Sena, et al.
Publicado: (2019)

Evaluation of Plasmodium vivax malaria recurrence in Brazil
por: Daher, André, et al.
Publicado: (2019)

Anti-band 3 and anti-spectrin antibodies are increased in Plasmodium vivax infection and are associated with anemia
por: Mourão, Luiza Carvalho, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2f54hlee4mgcmlgqumqr3572ru